Home › Immunoblastic Lymphadenopathy › Massachusetts › Boston
Immunoblastic Lymphadenopathy clinical trials in Boston, MA
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Massachusetts General Hospital, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- Durham, NC4 studies
- Miami, FL4 studies
- Baldwin Park, CA3 studies
- Ann Arbor, MI3 studies
- St. Louis, MO3 studies
- New Haven, CT3 studies
- Columbus, OH3 studies
- Atlanta, GA3 studies
- Rochester, MN3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.